Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-06-11
1996-04-09
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514923, A61K 3116
Patent
active
055062687
ABSTRACT:
Isovaleramide has been found to exhibit mild anxiolytic activity at low to moderate dosage levels and mildly sedative at somewhat higher dosage levels. In contrast to certain other materials thought to be anxiolytic or mildly sedative, isovaleramide is non-cytotoxic and does not paradoxically stimulate the central nervous system. Isovaleramide is therefore useful as a mild anxiolytic and mild sedative which can be made available to the general public.
REFERENCES:
patent: 4205083 (1980-05-01), Thies
patent: 4246282 (1981-01-01), Chignac et al.
patent: 4391819 (1983-07-01), Thies et al.
patent: 5300507 (1994-04-01), Yous et al.
The Merck Index (1989) 11th edition, #5118-#5124.
Allport, N. L., ed., The Chemistry and Pharmacy of Vegetable Drugs Chemical Publishing Company, Inc., Brooklyn, New York, (1944) pp. 159-161.
Bringmann, G., "A first biosynthetic proposal for the in vivo formation of naturally occurring diazepam-like 1,4-benzodiazepines" J. Neural. Trans. (1992) 88:77-82.
Burger, A., ed., Medicinal Chemistry Interscience Publishers, Inc., New York, New York (1951) vol. 1, pp. 113-114 and 128-137.
Burger, A., ed., Medicinal Chemistry 2nd Edition, Interscience Publishers, Inc., New York, New York, (1960) vol. 11, pp. 357-359, 362, 369, 370-375.
Burger, A., ed., Medicinal Chemistry 3rd Edition, Wiley-Interscience, New York, New York, (1970) vol. II, pp. 1365-1394, 1397-1401.
Burtner, R. R., et al., "The hypnotic properties of some derivatives of trihalogenated alcohols" J. Pharmacol. Exptl. Therap. (1938) 63:183-192.
Byrum, W. R., et al., "Preliminary pharmacological studies of some amides of chloral and alpha, alpha, beta-Trichlorobutyraldehyde" J. Am. Pharm. Assoc., Sci. Ed. (1952) 41:100-102.
Case, J. D., et al., "Sedormid-induced porphyria in the rat" Proc. Soc. Exptl. Biol. Med. (1953) 83:566-568.
Christmas, A. J., et al., "A comparison of the effects of some benzodiazepines and other drugs on aggressive and exploratory behaviour in mice and rats" Neuropharmacology (1979) 9:17-29.
de Barreiro, O. C., "Effect of sedormid chlorpromazine, and iproniazid on the activity of UDP-glucuronate glucuronyl transferase in rat liver: A histological study" Biochem. Pharmacol. (1965) 14:1694-1696.
Eeckhout, A. V. D., "The hypnotic action of members of the valerianic acid group" Chem. Abstr. (1908) 2:668.
Eeckhout, A. V. D., "Studien uber die hypnotische wirkung in der valerian-sauregruppe" Arch. Exptl. Pathol. Pharmako. (1907) 57:338-357. A partial English translation is also enclosed.
Foye, W. O., ed., Principles of Medicinal Chemistry 3rd Edition, Lea & Febiger, Philadelphia, Pennsylvania, (1989), Chapter 8, pp. 143-237.
Gilman, A. G., et al., eds. The Pharmaceutical Basis of Therapeutics 8th Edition, Permagon Press, New York, New York, (1990) pp. 345-436, 450-453.
Goldberg, A., et al., "Experimentally produced porphyria in animals" Proc. Roy. Soc., Ser. B. (Biol.Sci.) (1955) 143:257-280.
Goldberg, A., et al., eds., Diseases of Porphyrin Metabolism Charles C. Thomas Publishers, Springfield, Illinois, (1962) Chapter VIII, pp. 175-199.
Goldberg, M. et al., "Effects of a new tranquilzer, valmethamide, in psychiatric outpatient care" Dis. Nerv. Syst. (1961) 22:346-348.
Granick, S., "Hepatic porphyria and drug-induced or chemical porphyria" Ann. N.Y. Acad. Sci. (1965) 123:188-197.
Grier, J., "Valerian: its history, constituents and uses" Chemist Druggist (1929) 110:420-422.
Hare, H. A., et al., eds., The National Standard Dispensatory Lea Brothers, Inc., New York, New, York, (1905) pp. 93-94, 129-130, 159-160, 169, 550, 642, 692-693, 1031, 1426, 1480, 1571-1572, 1619-1620, 1631, 1633, 1661-1662.
Hirsch, G. H., et al., "Studies of the relationship between chemical structure and porphyria-inducing activity-III." Biochem. Pharmacol. (1967) 16(18):1455-1462.
Hirsch, G. H., et al., "Studies of the relationship between chemical structure and porphyria-inducing activity-II." Biochem. Pharmacol. (1967) 15:1006-1008.
Hobbs, C., "Valerian, a literature review" Herbalgram (1989) No. 21, pp. 19-34 and No. 23, pp. 4, 47-48.
Houghton, P. J., "The biological activity of valerian and related plants" J. Ethnopharmacology (1988) 22:121-142.
Impens, E., "Pharmakologisches uber luminal oder phenylathybarbitursaure" Deut. Med. Worchschr. (1912) 38:945-947.
Irwin, S., "Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse" Physchopharmacologia (1968) 13:222-257.
Jenkins, G. L., et al., The Chemistry of Organic Medicinal Products 2nd Edition, John Wiley & Sons, Inc., London, England, (1943) pp. 214-215, 374-383, and 616-621.
Junkmann, K., "Studien uber die hypnotische wirkung substituierter acetamide" Arch. Expl. Pathol. Pharmako. (1937) 186:552-564.
Junkmann, K., "Einiges uber spasmolytica" Arch. Expt. Pathol. Pharmako. (1940) 195:175-183.
Klotz, U., et al., "Occurrence of `natural` benzodiazepines" Life Sci. (1991) 48:209-215.
Krieglstein, V., J., et al., "Zentral dampfende inhaltsstoffe im bladrian" Deut. Apoth. Zeitung. (1988) 128:2041-2046.
Marks, G. S., et al., "Studies of the relationship between chemical structure and porphyria-inducing activity" Biochem. Pharmacol. (1965) 14:1077-1084.
Marks, P. A., et al., "Drug-induced hemolytic anemias associated with glucose-6-phosphate dehydrogenase deficiency: A genetically heterologous trait" Ann. N.Y. Acad. Sci. (1965) 123:198-206.
May, P., The Chemistry of Synthetic Drugs Longmans, Green and Company, London, England, (1921) pp. 24-25, 186-188, 234-235.
Meyer, K. H., et al., "Beitrage zur theorie der narkose" Biochem. Z. (1935) 277:39-71.
Nelson, J. W., et al., "A pharmaceutical study of some new synthetic hypnotics" J. Am. Pharm. Assoc., Sci Ed. (1941) 30:180-182.
Petersen, E. N. et al., "A water lick conflict paradigm using drug experienced rats" Psychopharmacology (1981) 75:236-239.
Richards, A. N. "Pharmacology of luminal or phyenlethylbarbituric acid" Chem. Abstr. (1912) 6:2109-2110.
Rosecrans, J. A. et al., "Pharmacological investigation of certain Valeriana officinalis L. extracts" J. Pharm. Sci. (1961) 50(3):240-244.
Roszkowski, A. P. et al, "Behavioral and central muscle relaxant properties of 2-ethyl-3-methylvaleramide" Int. J. Neuropharmacol. (1962) 1:423-430.
Samson, F. E., Jr., et al., "A study on the narcotic action of the short chain fatty acids" J. Clin. Invest. (1956) 35(2):1291-1298.
Schmid, R., et al., "Experimental porphyria. III. Hepatic type produced by sedormid" Proc. Soc. Exptl. Biol. Med. (1952) 81:685-689.
Schneck, D. W., et al., "Studies of the relationship between chemical structure and porphyria-inducing activity-IV." Biochem. Pharmacol. (1968) 17(7):1385-1399.
Schneck, D. W., et al., "Studies of the relationship between chemical structure and porphyria-inducing activity-V." Biochem. Pharmacol. (1972) 21(7):2509-2518.
Sepinwall, J., et al, "Behavioral pharmacology of antianxiety drugs" Handbook of Psychopharmacology Plenum Press, New York, New York, Iverson, L. L., et al., eds., (1978) vol. 13, Chapter 6, pp. 345-393.
Slater, I. H., et al, "Diethylbutanediol, a convulsant homologue of the depressant, diethylpropanediol" J. Pharmacol. Exptl. Therap. (1954) 111:182-196.
Stepansky, W., "A clinical study in the use of valmethamide, an anxiety-reducing drug" Curr. Ther. Res. 1960) 2:144-147.
Talman, E. L., et al., "Porphyrin metabolism. IV. Molecular structure of acetamide derivatives affecting porphyrin metabolism" Arch. Biochem. Biophys. (1957) 66:2389-300.
Talman, E. L., et., "Porphyrin metabolism. I. Experimental porphyria in chick embryos" J. Bio. Chem. (1955) 212:663-675.
Teychenne. P. F., et al., "The encephalopathic action of five-carbon-atom fatty acids in the rabbit" Clin. Sci. Mol. Med. (1976) 50(6):463-472.
Unseld, E., et al., "Detection of desmethyldiazepam and diazepam in brain of different species and plants" Biochem. Pharmacol. (1989) 38(15):2473-2478.
Volwiler, E. H., et al., "Some alkyl and aryl amides and ureides as hypnotics" J. Amer. Chem. Soc. (1936) 58:1352-1354.
Wagner, H., et al., "In vitro- und in vivo-metabolismus von .s
Balandrin Manuel F.
Van Wagenen Bradford C.
Geist Gary
Harris C.
NPS Pharmaceuticals Inc.
LandOfFree
Use of isovaleramide as a mild anxiolytic and sedative agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of isovaleramide as a mild anxiolytic and sedative agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isovaleramide as a mild anxiolytic and sedative agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139618